VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 115 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,351,088 | -27.2% | 2,164,558 | +11.0% | 0.00% | -25.0% |
| Q2 2023 | $12,846,763 | -32.0% | 1,949,383 | -30.0% | 0.00% | -33.3% |
| Q1 2023 | $18,900,993 | +89529.1% | 2,783,690 | -2.5% | 0.01% | 0.0% |
| Q4 2022 | $21,088 | -99.9% | 2,853,832 | +4.3% | 0.01% | -40.0% |
| Q3 2022 | $27,021,000 | -7.5% | 2,734,976 | +2.1% | 0.01% | 0.0% |
| Q2 2022 | $29,212,000 | +14.1% | 2,680,025 | +18.4% | 0.01% | +25.0% |
| Q1 2022 | $25,597,000 | -19.8% | 2,263,159 | +11.3% | 0.01% | -20.0% |
| Q4 2021 | $31,909,000 | -3.5% | 2,033,578 | +5.4% | 0.01% | -9.1% |
| Q3 2021 | $33,078,000 | -21.8% | 1,929,882 | -1.9% | 0.01% | -15.4% |
| Q2 2021 | $42,294,000 | +62.9% | 1,966,427 | +13.8% | 0.01% | +44.4% |
| Q1 2021 | $25,960,000 | +27.3% | 1,728,361 | +11.3% | 0.01% | +28.6% |
| Q4 2020 | $20,397,000 | +43.9% | 1,552,238 | +5.8% | 0.01% | +16.7% |
| Q3 2020 | $14,177,000 | -13.5% | 1,467,665 | +2.4% | 0.01% | -14.3% |
| Q2 2020 | $16,393,000 | +18.5% | 1,433,008 | +7.3% | 0.01% | 0.0% |
| Q1 2020 | $13,831,000 | -29.6% | 1,335,345 | +11.5% | 0.01% | 0.0% |
| Q4 2019 | $19,655,000 | +32.0% | 1,197,721 | +6.9% | 0.01% | +16.7% |
| Q3 2019 | $14,886,000 | +9.2% | 1,120,916 | +15.9% | 0.01% | +20.0% |
| Q2 2019 | $13,631,000 | -5.6% | 967,404 | +23.3% | 0.01% | -16.7% |
| Q1 2019 | $14,438,000 | +4.1% | 784,618 | +47.8% | 0.01% | 0.0% |
| Q4 2018 | $13,867,000 | +132.5% | 530,705 | +104.2% | 0.01% | +200.0% |
| Q3 2018 | $5,965,000 | +2022.8% | 259,910 | +934.3% | 0.00% | – |
| Q2 2016 | $281,000 | +33.8% | 25,128 | 0.0% | 0.00% | – |
| Q1 2016 | $210,000 | -2.3% | 25,128 | +8.6% | 0.00% | – |
| Q4 2015 | $215,000 | -10.0% | 23,128 | +9.0% | 0.00% | – |
| Q3 2015 | $239,000 | +4.8% | 21,228 | +18.4% | 0.00% | – |
| Q2 2015 | $228,000 | – | 17,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |